Recombinant Anti-CD2 x Anti-TCR (Vβ8) Bispecific Antibody (scFv-IgG) is formed by an IgG and two scFv fragments. The scFvs from an anti-CD2 antibody variable domain are respectively connected to the N terminus of the anti-TCR (Vβ8) IgG heavy chains or light chains to form scFv-(H)IgG or scFv-(L)IgG. It is a type of appended IgGs and has 2+2 antigen-binding valency. This BsAb can activate T cells. It is designed for the research of Tumors therapy.